Navigation Links
NEWSWEEK: Media Lead Sheet/November 19, 2007 Issue (on newsstands Monday, November 12)
Date:11/11/2007

COVER: "1968: The Year That Made Us Who We Are" (p. 42). "There was at the end of 1968 an event that remains an inspirational symbol for the challenges ahead. For the Sixties were also the glory years of the American space program, and of astronauts such as Captain Jim Lovell," writes former NBC News anchor Tom Brokaw, in his forthcoming book, "BOOM! Voices of the Sixties," excerpted in the cover package in which Newsweek looks back at one of the defining years of the 1960s -- 1968 -- a turbulent period in American history. Senior Writer and Political Correspondent Jonathan Darman writes that the 1968 election is four decades old, and yet we're still rehashing that moment-that era-in the 2008 contest. Barack Obama was born in the 1960s, but is not of them. Such is the constant promise -- I am not the '60s -- of his presidential campaign-heartfelt, but ultimately hard to believe. Just look at the gray- haired '60s idealists inside the senator's own brain trust who see him as the fulfillment of 40 years' worth of hard work. John McCain is also the '60s. McCain knows what Obama should have learned by now: the '60s are impossible to escape. They will define the 2008 presidential election, just as they have defined American politics, and American culture, for the past 40 years.

http://www.newsweek.com/id/69637

(Photo: http://www.newscom.com/cgi-bin/prnh/20071111/NYSU004 )

"The Worst Week" (p. 44). Editor-at-Large Evan Thomas writes that in a year of tumult, one five-day span in early spring '68 was disorder distilled culminating in the assassination of King. Lyndon Johnson's presidency was collapsing. Robert Kennedy had openly announced his intention to reclaim the throne in the memory of his brother. Martin Luther King Jr., the civil rights leader, was on his way back to Memphis to rally striking sanitatio
'/>"/>

SOURCE Newsweek
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24).
2. NEWSWEEK: Cover: Giving Globally: How to Heal the World
3. NEWSWEEK: Cover: Kids and the Growing Food Allergy Threat
4. NEWSWEEK: Media Lead Sheet/November 5, 2007 Issue (on newsstands Monday, October 29).
5. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
6. AUDIO from Medialink and Kelloggs: Whats in Your Water?
7. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
8. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
9. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
10. Weiner Public News First Media Team at National Press Club 5K
11. VIDEO from Medialink and General Motors: On and Off the Track
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...eases production of neural stem cells , ,...ts in mice, exercise appears to reverse the declin...en with aging, Taiwanese researchers report. , ... to stave off aging appears to be due to exercise,...tial for the production of new brain cells. , ...
(Date:11/21/2008)...re/ -- A prestigious group of physicians, nurses, ...liamsburg, VA on March 27-29, 2009 at the Williams...n on cutting-edge therapeutic protocols, novel dia...es that impact patient care. The full program, fac...is available at www.bioconferences.com/wh , ...
(Date:11/21/2008)...ity of Texas M. D. Anderson Cancer Center marked t...e breast cancer in Panama through the Partnership ...ericas today at an event with Laura Bush, the Firs...e Torrijos, the First Lady of Panama. , Joinin...partment of State and Susan G. Komen for the Cure ...
(Date:11/21/2008)...ew inventions in computerized brain,training may ...es lead fuller,lives, said Jeff Zimman, Chairman ... today at the annual Technology Innovators Confere... National Center for Technology Innovation to,pro.... , Zimman said cognitive training programs...
Breaking Medicine News(10 mins):Health News:Exercise Keeps the Brain Young 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2Health News:New Applications for Cognitive Training 2
...g the 2008 Olympics as its launch pad, China is ex...m destination by 2014. Experts interviewed by a...n foreign tourists in 2006, excluding arrivals fro...d Taiwan, compared to a mere 300,000 in 1978. The...
...ersity of Cincinnati researchers have identified a...tial biological target for pancreatic cancer. L...dy found that the RON receptor tyrosine kinase was...r cells, suggesting that the receptor may also con...
...there is a cure for smelly and pongy feet - specia...rst eco-friendly sock to go on general sale, and e...of the biggest revolutions to take place in the wo...socks, to be launched by supermarket chain Asda, a...
...eems that Victoria Beckham has imposed a strict di... world tour that is to begin later this year. Th...d all the four members to go on a diet of edamame ... lettuce and all this combined with 200 sit ups a ...
Other Medicine News:Health News:China to Replace France as World's Top Tourism Destination by 2014 2Health News:Scientists Identify New Possible 'biomarker' for Pancreatic Cancer 2
(Date:11/21/2008)... , - Not for UK J...icinal Products for Human Use (CHMP) today,announ...f Enbrel(R),(etanercept) as a treatment for child...vere plaque psoriasis. If approved by the European...tion, Enbrel will become the,first biologic treat...
(Date:11/20/2008)...PHIA, Nov. 20 GlaxoSmithK...d States Food and Drug Administration (FDA) grante...g) for the treatment of thrombocytopenia in patien...ic purpura (ITP) who have had an insufficient resp...ctomy. The approval is a significant milestone for...
(Date:11/20/2008)...swire-FirstCall/ -- Duska Therapeutics,Inc., (OT...as submitted its,pivotal Phase 3 ATPace clinical ...l Assessment (SPA) procedure with the U.S. Food an...securing an agreement with the FDA, Duska intends ...placebo-controlled and randomized Phase 3,clinica...
(Date:11/19/2008)...re/ -- Posit Science Corporation,researcher, Dan ...oscience,Annual Conference in Washington, DC this...fit Baby Boomers. The computerized brain plastici... exercises that target auditory and,language syst...zed,improvements in cognition by improving speed ...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Long Term Data from a Landmark Phase III Trial Show Survival Benefit at Three and Four Years in Patients with Glioblastoma multiforme 698 1Long Term Data from a Landmark Phase III Trial Show Survival Benefit at Three and Four Years in Patients with Glioblastoma multiforme 698 2Long Term Data from a Landmark Phase III Trial Show Survival Benefit at Three and Four Years in Patients with Glioblastoma multiforme 698 3Long Term Data from a Landmark Phase III Trial Show Survival Benefit at Three and Four Years in Patients with Glioblastoma multiforme 698 4Long Term Data from a Landmark Phase III Trial Show Survival Benefit at Three and Four Years in Patients with Glioblastoma multiforme 698 5CEL SCI to Present at Rodman 26 Renshaw 9th Annual Healthcare Conference 695 1CEL SCI to Present at Rodman 26 Renshaw 9th Annual Healthcare Conference 695 2AIDS Stopped in Haiti Before U S 4956 1AIDS Stopped in Haiti Before U S 4956 2AIDS Stopped in Haiti Before U S 4956 3Neurobiological Technologies Announces Pricing of Its 2460 Million Common Stock Offering 1579 1Neurobiological Technologies Announces Pricing of Its 2460 Million Common Stock Offering 1579 2
...th Humira Estimated to Increase the,Maximal Steady...0%,-, SAN DIEGO, July 09, 2007 /PRNewswire-FirstCa...utical company developing and,commercializing reco...results of the Enhanze(TM) Technology clinical tri...bility of a,representative commercially-available ...
...S WIRE)--Jul 11, 2007 - BioSante,Pharmaceuticals, ...lts demonstrating that its calcium phosphate (CaP)... may serve as an,effective vaccine adjuvant for th...N1 avian flu, widely known as bird flu., The new r...on,inhibition assay (HAI), which showed the clear ...
Other Medicine Technology:Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 2Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 3Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 5BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 2BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 3BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 4
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: